Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Danny Sullivan
Contributing editor to Longevity Technology
Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Details last updated 10-Feb-2020
Articles written by Danny Sullivan
Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025Somite AI uses DeltaStem to speed up and scale stem cell engineering
BrightFocus Foundation fuels early research on aging diseases with $13m grants
Longevity Technology - 13-May-2025Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Rewriting the cell's code: HAYA’s mission to transform genomic medicine
Longevity Technology - 12-May-2025Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states
Hundred health acquires BellSant to supercharge AI longevity platform strapline:
Longevity Technology - 08-May-2025AI-driven health platform gears up for launch with cutting-edge longevity data
NewLimit secures $130m to accelerate epigenetic reprogramming for longevity
Longevity Technology - 06-May-2025The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan
Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025HepaRegeniX advances trials for a novel liver regeneration therapy
Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025A next-gen retinal implant offers new hope for vision loss from macular degeneration
New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025It avoids common delivery problems and enters Phase 1 trials in 2025
Tribune Therapeutics secures 37m to tackle fibrosis at its source
Longevity Technology - 28-Mar-2025Scandinavian biotech targets fibrosis with novel scar-blocking therapies
Mito Health raised $4 million to grow its AI-powered health platform
Longevity Technology - 18-Mar-2025It uses blood tests to find early health risks and gives personalised advice
Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs
Longevity Technology - 12-Mar-2025Clinical trials are beginning, backed by major investors like Novo Holdings
Trimtech secures $31m to tackle neurodegenerative diseases
Longevity Technology - 06-Mar-2025Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Europe’s first 100m consumer health fund targets proactive care revolution
Longevity Technology - 18-Feb-2025naturalX backs startups reshaping wellness and prevention
Mair Therapeutics targets Parkinson’s with AI-driven drug discovery
Longevity Technology - 17-Feb-2025The Dutch startup is using ion channel research and advanced tech to develop new treatments
Junevity secures $10m to pioneer “cell reset” therapies for longevity
Longevity Technology - 13-Feb-2025Backed by AI and genetics, Junevity targets age-related diseases
Nucleus brings whole-genome health testing to the masses
Longevity Technology - 30-Jan-2025Cutting-edge DNA analysis provides affordable, real-time health insights
Neko Health secures $260m to revolutionize preventive care
Longevity Technology - 23-Jan-2025Full-body scans drive early detection as Neko expands globally
Display all articles
